These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35573885)

  • 1. Pharmacokinetics, distribution, and excretion of sodium oligomannate, a recently approved anti-Alzheimer's disease drug in China.
    Lu J; Pan Q; Zhou J; Weng Y; Chen K; Shi L; Zhu G; Chen C; Li L; Geng M; Zhang Z
    J Pharm Anal; 2022 Feb; 12(1):145-155. PubMed ID: 35573885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of LC-MS/MS method for quantitation of sodium oligomannate in human plasma, urine and feces.
    Zhang Z; Yang X; Zhang L; Zhu H; Huang B; Chen Q; Wang Y; Yu C; Bi L; Geng M; Li L
    Bioanalysis; 2023 Apr; 15(7):371-390. PubMed ID: 37057990
    [No Abstract]   [Full Text] [Related]  

  • 3. Sodium Oligomannate: First Approval.
    Syed YY
    Drugs; 2020 Mar; 80(4):441-444. PubMed ID: 32020555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics, Bioavailability, Excretion and Metabolism Studies of Akebia Saponin D in Rats: Causes of the Ultra-Low Oral Bioavailability and Metabolic Pathway.
    Li P; Peng J; Li Y; Gong L; Lv Y; Liu H; Zhang T; Yang S; Liu H; Li J; Liu L
    Front Pharmacol; 2021; 12():621003. PubMed ID: 33935711
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolism and excretion of trovafloxacin, a new quinolone antibiotic, in Sprague-Dawley rats and beagle dogs. Effect of bile duct cannulation on excretion pathways.
    Dalvie DK; Khosla NB; Navetta KA; Brighty KE
    Drug Metab Dispos; 1996 Nov; 24(11):1231-40. PubMed ID: 8937858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer's dementia.
    Xiao S; Chan P; Wang T; Hong Z; Wang S; Kuang W; He J; Pan X; Zhou Y; Ji Y; Wang L; Cheng Y; Peng Y; Ye Q; Wang X; Wu Y; Qu Q; Chen S; Li S; Chen W; Xu J; Peng D; Zhao Z; Li Y; Zhang J; Du Y; Chen W; Fan D; Yan Y; Liu X; Zhang W; Luo B; Wu W; Shen L; Liu C; Mao P; Wang Q; Zhao Q; Guo Q; Zhou Y; Li Y; Jiang L; Ren W; Ouyang Y; Wang Y; Liu S; Jia J; Zhang N; Liu Z; He R; Feng T; Lu W; Tang H; Gao P; Zhang Y; Chen L; Wang L; Yin Y; Xu Q; Xiao J; Cong L; Cheng X; Zhang H; Gao D; Xia M; Lian T; Peng G; Zhang X; Jiao B; Hu H; Chen X; Guan Y; Cui R; Huang Q; Xin X; Chen H; Ding Y; Zhang J; Feng T; Cantillon M; Chen K; Cummings JL; Ding J; Geng M; Zhang Z
    Alzheimers Res Ther; 2021 Mar; 13(1):62. PubMed ID: 33731209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats.
    Egorin MJ; Lagattuta TF; Hamburger DR; Covey JM; White KD; Musser SM; Eiseman JL
    Cancer Chemother Pharmacol; 2002 Jan; 49(1):7-19. PubMed ID: 11855755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.
    Sugihara K; Morino A; Nomura A; Iida S; Sugiyama M
    Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and disposition of the novel dopamine agonist Z-7760 in rat after intravenous and oral administration.
    Bollard M; Caldwell J; Taylor GW; Strolin-Benedetti M; Semeraro C
    Xenobiotica; 2000 Oct; 30(10):983-91. PubMed ID: 11315106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, tissue distribution, and excretion of sitafloxacin, a new fluoroquinolone antibiotic, in rats, dogs, and monkeys.
    Tachibana M; Tanaka M; Mitsugi K; Jin Y; Takaichi M; Okazaki O
    Arzneimittelforschung; 2004; 54(12):898-905. PubMed ID: 15646375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel double-tracer technique to characterize absorption, distribution, metabolism and excretion (ADME) of [14C]tofogliflozin after oral administration and concomitant intravenous microdose administration of [13C]tofogliflozin in humans.
    Schwab D; Portron A; Backholer Z; Lausecker B; Kawashima K
    Clin Pharmacokinet; 2013 Jun; 52(6):463-73. PubMed ID: 23494983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral absorption, distribution, metabolism, and excretion of icaritin in rats by Q-TOF and UHPLC-MS/MS.
    Zhang SQ; Zhang SZ
    Drug Test Anal; 2017 Oct; 9(10):1604-1610. PubMed ID: 28303675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition, oral bioavailability, and tissue distribution of zearalenone in rats at various dose levels.
    Shin BS; Hong SH; Bulitta JB; Hwang SW; Kim HJ; Lee JB; Yang SD; Kim JE; Yoon HS; Kim DJ; Yoo SD
    J Toxicol Environ Health A; 2009; 72(21-22):1406-11. PubMed ID: 20077212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.
    Kamath AV; Wang J; Lee FY; Marathe PH
    Cancer Chemother Pharmacol; 2008 Mar; 61(3):365-76. PubMed ID: 17429625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics, bioavailability and tissue distribution study of JCC-02, a novel N-methyl-d-aspartate (NMDA) receptor inhibitor, in rats by LC-MS/MS.
    Yang T; Shi Y; Lin C; Yan C; Zhang D; Lin J
    Eur J Pharm Sci; 2019 Apr; 131():146-152. PubMed ID: 30776467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
    Fagerholm U; Breuer O; Swedmark S; Hoogstraate J
    J Pharm Pharmacol; 2005 May; 57(5):587-97. PubMed ID: 15901348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of TDP223206 following intravenous and oral administration to intact rats and intravenous administration to bile duct-cannulated rats.
    Chen Y; Cheng D; Marugan JJ; Manthey C; Tomczuk B; Huebert N
    Biopharm Drug Dispos; 2008 May; 29(4):219-30. PubMed ID: 18260095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
    Okuyama Y; Momota K; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.
    Prakash C; Soliman V
    Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.